TP53 and non-small cell lung carcinoma: Our study demonstrates that AKBA, when combined with Cis, significantly enhances apoptosis in A549 NSCLC cells, primarily through upregulation of pro-apoptotic genes p53 and caspase-3 and downregulation of the inflammatory transcription factor NF-κB.